MetaCap

Bone Biologics (BBLG) vs Lifeward (LFWD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Lifeward is the larger company by market cap ($17.8 million vs $1.3 million), about 13.8 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

BBLG versus LFWD key metrics
MetricBBLGLFWD
Share price$0.468$6.29
Market cap$1.29M$17.81M
1-day change-4.00%-3.27%
YTD return—-6.12%
1-year return—-32.21%
5-year return—-94.31%
EPS (TTM)$-1.37$-15.73
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2.79$10.10
52-week low$0.428$4.14
Distance from 52-week high-83.23%-37.77%
Average volume378.57K6.15K
Shares outstanding2.76M2.83M
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Lifeward is about 13.8 times larger than Bone Biologics by market value ($17.81M vs $1.29M).

BBLG vs LFWD FAQ

Which is bigger, Bone Biologics or Lifeward?

Lifeward (LFWD) is larger, with a market capitalization of $17.81M compared with $1.29M for Bone Biologics (BBLG).

Are Bone Biologics and Lifeward in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons